Paulsens to Generate Strong ReturnsSIGNIFICANT IMPROVEMENT AND GROWTH OPPORTUNITIES
The May 2024 Study is a subset of an Internal Operating Plan which includes additional mining areas that do not meetrequirements for public release as some Inferred Resources and Exploration Targets are included. The Internal OperatingPlan may provide substantial opportunities that the Company expects to realise once operational. These potentialopportunities includeeveloped, High-Grade Veins: Historically, the focus of mining was within the Main Zone, with the Footwall **bro Zone mostly overlooked. Numerous unmined Footwall **bro Zone veins within existing access drives contain thick, high-grade intercepts as identified by historical and recent wall/face sampling (Figure 3 and Figure 4). Due to limited drilling, most sampled areas are outside of the recently announced Resource of 406koz @ 9.5g/t Au and are not included in the May 2024 Study.
These potential walk-up mining opportunities may contribute additional high-grade feed.High-Grade Stockpile Strategy: The Internal Operating Plan includes selective mining of exposed and unmined,high-grade veins to build a high-grade stockpile for immediate processing once the processing facility is commissioned. This has the potential to increase and accelerate the initial and life of mine cash flow. The high-grade stockpile strategy, while excluded from the May 2024 Study, will commence immediately upon full funding.
By way of example, Figure 4 shows a face sampled at 3.4m @ 75.78g/t Au5 that is not in Resource/production target but which is in the Internal Operating Plan. An estimated Exploration Targets of 400-520kt @ 9-12g/t Au for 100-200koz relating to exposed and unmined, high-grade veins (Table 6) is excluded from the May 2024 Study.
- Forums
- ASX - By Stock
- BC8
- Ann: Paulsens to Generate Strong Returns - Study Update
Ann: Paulsens to Generate Strong Returns - Study Update, page-5
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BC8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
-0.020(6.78%) |
Mkt cap ! $84.85M |
Open | High | Low | Value | Volume |
29.0¢ | 29.3¢ | 27.5¢ | $434.5K | 1.531M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 94822 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 204666 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 94822 | 0.275 |
9 | 404036 | 0.270 |
3 | 70324 | 0.265 |
2 | 105920 | 0.260 |
3 | 19568 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 204666 | 6 |
0.295 | 3300 | 1 |
0.300 | 48133 | 3 |
0.315 | 40000 | 2 |
0.320 | 55700 | 2 |
Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
27.5¢ |
  |
Change
-0.020 ( 7.81 %) |
|||
Open | High | Low | Volume | ||
29.0¢ | 29.3¢ | 27.5¢ | 1400544 | ||
Last updated 15.59pm 12/06/2024 ? |
Featured News
BC8 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online